SCHEMBL5535331

SCHEMBL5535331

CC(CCc1cnc(Nc2cccc(Cl)c2Cl)nc1N)N(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
IGF1R P08069 2/20 0.34
DHFR P00374 2/20 0.34
MAPT P10636 1/20 0.34
PTPN11 Q06124 2/20 0.33
RAB9A P51151 2/20 0.33
CNR2 P34972 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
LRRK2 Q5S007 2/20 0.33
INSR P06213 1/20 0.32
ALK Q9UM73 1/20 0.32
HTR1A P08908 1/20 0.32
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
HTR7 P34969 1/20 0.32
HTR6 P50406 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5522754 0.91 IGF1R (0.43) IGF1RDHFRRAB9ASMN1; SMN2LRRK2
SCHEMBL5528704 0.88 TNK2 (0.36) LMNADHFR
SCHEMBL2114807 0.84 LMNA (0.50) LMNAIGF1RPTPN11INSRALK
SCHEMBL5525987 0.84 NPC1 (0.41) LMNADHFRRAB9ASMN1; SMN2LRRK2
SCHEMBL5529329 0.84 HTT (0.45) LMNAMAPTRAB9ASMN1; SMN2LRRK2
SCHEMBL5525215 0.83 DHFR (0.39) IGF1RDHFRRAB9ACNR2SMN1; SMN2
SCHEMBL4199140 0.83 KDM4E (0.41) IGF1RDHFRMAPTRAB9ACNR2
SCHEMBL5530876 0.83 CNR2 (0.34) DHFRMAPTRAB9ACNR2ALK
SCHEMBL5523567 0.83 MAPT (0.38) MAPTRAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL2114726 0.83 LMNA (0.48) LMNAIGF1RPTPN11MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES PRKCA, PRKCH, PRKCG LMNA 975/4885IGF1R 4009/4885DHFR 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.